Life situation of women impaired by Thalidomide embryopathy in North Rhine-Westphalia - a comparative analysis of a recent cross-sectional study with earlier data
Open Access
- 3 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 19 (1) , 51
Abstract
Between 1957 and 1961 the substance Thalidomide was sold in West Germany and taken by many women as a sedative during pregnancy. This lead to miscarriages and infants been born with several severe malformations. The aim of this study was to describe the current situation of women impaired by Thalidomide induced embryopahty in North Rhine-Westphalia (Nordrhein-Westfalen), Germany, in comparison with the results found in a study done in 2002 by Nippert et al. Questionnaires as well as examinations were performed. Data were compared using descriptive and inductive statistical methods. Both studies show that women impaired by Thalidomide embryopathy face a poorer health status than women their age in the general population and live in fear of further deteriorating health. The majority can only work reduced hours or are already retired due to poor health. Most of those who need assistance are being assisted by their social environment, while professional care is still utilized in only few cases. An obvious need for a shift in the provision of assistance and/or care provided was found as the social environment supporting the impaired women is also aging and therefore in high danger of breaking apart. The study has been registered at German Clinical Trials Register, DRKS00010593 , on 07.06.2016 retrospectively.Keywords
Funding Information
- Landeszentrum Gesundheit NRW (2010/S250-288194)
- Innovative Medizinische Forschung, Westfälische Wilhelms-Universität Münster (NI-1-1II/96-11)
This publication has 40 references indexed in Scilit:
- Thalidomide Embryopathy: An Enigmatic ChallengeISRN Developmental Biology, 2013
- Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of DiseaseToxicological Sciences, 2011
- Thalidomide embryopathy cases in Brazil after 1965Reproductive Toxicology, 2006
- Validity of self reported diagnoses of cancer in a major Spanish prospective cohort studyJournal of Epidemiology and Community Health, 2006
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential usesTeratology, 1999
- Education and occupational social class: which is the more important indicator of mortality risk?Journal of Epidemiology and Community Health, 1998
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- THALIDOMIDE IN JAPANThe Lancet, 1963